129 results
8-K
EX-99.1
fw8u0l4jsl a9bmjp
13 Mar 24
Coherus BioSciences Reports Fourth Quarter, Full Year 2023 Financial Results and Provides Current Business Update
4:16pm
8-K
EX-99.2
gcq1ga
4 Mar 24
Completion of Acquisition or Disposition of Assets
6:22am
8-K
EX-2.1
kndjaffc7gdrbugacyp3
22 Jan 24
Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in Conference Call Information
8:01am
8-K
EX-99.1
euf 4sbi5p7l
6 Nov 23
Coherus BioSciences Reports Third Quarter 2023 Financial Results and Business Highlights
4:31pm
8-K/A
EX-99.2
ogw9af2842d4swrwhg
6 Nov 23
Report of Independent Registered Public Accounting Firm
6:07am
8-K/A
EX-99.1
jhs5tr
6 Nov 23
Report of Independent Registered Public Accounting Firm
6:07am
424B5
0ecfc
12 Sep 23
Prospectus supplement for primary offering
6:04am
8-K
EX-99.1
iclk534 z0dq
2 Aug 23
Coherus BioSciences Reports Second Quarter 2023 Financial Results and Business Highlights
4:05pm
424B3
uzujb
26 Jul 23
Prospectus supplement
4:59pm
S-4/A
u7wh5ylmjty0c1muw
24 Jul 23
Registration of securities issued in business combination transactions (amended)
4:42pm
S-4
jwnkf7i bpyu
7 Jul 23
Registration of securities issued in business combination transactions
5:03pm
425
ofheqp2f59iy d36ng
16 Jun 23
Business combination disclosure
8:08am